With Novo Nordisk success, is there a "Nokia risk" for Denmark?
Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.
Watch CBS News
Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.
New research suggests diabetes drugs like Ozempic, which some people also take to lose weight, may also help patients suffering from substance addiction. CBS News contributor Dr. Celene Gounder has more.
Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.
Weight loss drugs are exploding in popularity, with 1 in 8 Americans saying they have tried medications like Ozempic and Wegovy to tackle everything from diabetes to weight loss, among other conditions. As demand rises, many people are turning to copycat alternatives, or compounded versions, of the drugs. CBS News Confirmed looked into the marketplace for these alternatives and found plenty of gray area, with little oversight or protection for consumers.
The Senate Health, Education, Labor and Pension committee, led by Vermont Sen. Bernie Sanders, is hearing testimony from Novo Nordisk CEO Lars Fruergaard Jørgensen on the exhortative prices for their drugs in the U.S. CBS News' Nancy Chen has more.
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Eli Lilly is slashing prices for certain doses of its weight loss drug Zepbound, selling single-dose vials at much cheaper prices for people who pay out of pocket. Dr. Timothy Mackey, professor in the Global Health Program at the University of California, San Diego, joined CBS News to discuss the price cuts.
A new study found a link between popular weight loss drugs and suicidal thoughts, but there are questions about the scope and method of the study. Dr. Jonathan LaPook explains what to make of the findings.
Several doctors say the findings of a new study linking popular new weight loss drugs to the risk of suicide should be taken with a grain of salt. CBS News chief medical correspondent Dr. Jon LaPook has more.
CBS News chief medical correspondent Dr. Jon LaPook takes a look at new research that suggests popular drugs like Ozempic and Wegovy might help with other cravings.
A group of weight loss and diabetes treatment drugs, known as GLP-1 agonists, work by curbing appetite centers in the brain. But animal studies suggest these drugs could also potentially reduce addiction to nicotine, alcohol, and opioids. Dr. Jon LaPook explains.
Semaglutide, the active ingredient in drugs like Wegovy and Ozempic, can help people lose weight — and a new study says it may also help people quit smoking.
Novo Nordisk and Lilly can't keep up with demand for their weight loss drugs such as Ozempic, Wegovy and Mounjaro. But they object to specialty pharmacies making their own cheaper versions to fill the gap — providing as much as 30% of those drugs sold in the U.S.
Longtime customers of a men's shirt company are now buying clothes two sizes smaller, its owner said.
Even if someone has gone through a healing process with body image or their relationship with food, these challenges can "last a lifetime," a licensed mental health counselor tells CBS News.
As weight loss drugs like Ozempic and Wegovy become more popular, obesity medicine specialists are concerned that not enough physicians have received specialized training to help patients navigate the medicine. Dr. Celine Gounder, CBS News medical contributor and editor-at-large for public health at KFF, has more on the situation.
Vital Pursuit will include whole-grain bowls, protein pasta, sandwich melts and gluten-free options.
Rising prices, insurance hurdles and a supply shortage can make access difficult for people who rely on drugs like Ozempic for diabetes and obesity, especially low-income patients. Renu Rayasam, senior correspondent with KFF Health News, joined CBS News to discuss the situation.
Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.
While it may seem like everyone is taking Ozempic, not everyone can afford to. The high price of popular diabetes drugs prevents many people from getting them.
A joint investigation by Digital Citizens Alliance and Coalition for a Safer Web found dozens of TikTok profiles offering to ship weight loss drugs for lower prices and without a prescription. In nearly every situation, it was a scam.
Some claim "oatzempic," a drink that combines oats, water and lime juice, can help people drop weight fast — its name a nod to the popular weight loss drug Ozempic. Here's what experts say.